KIT and intrahepatic cholangiocarcinoma: Apart from the KIT signaling pathway, new mediators of ICC differentiation and proliferation have been described, such as neuronal nitric oxide (NO), the serotonergic receptor 5-HT2B, insulin, and the growth factor IGF-1, as well as immunomodulators such as interleukin-9 [13].